Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ingaron in HIV/TB Coinfection
NCT05065905Phase 2Completed
- Sponsor
- SPP Pharmaclon LTD
- Start
- Jan 2006
- Primary completion
- Mar 2006
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of Ingaron in human immunodeficiency virus infection (HIV), pulmonary tuberculosis (TB), sponsored by SPP Pharmaclon LTD. Started Jan 2006; status: completed.
02
Drugs
Ingaron
03
Conditions
human immunodeficiency virus infection (HIV)pulmonary tuberculosis (TB)
Beyond the preview
Go deeper on NCT05065905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05065905.